| 1 | Lymphoma, AIDS-Related | 45.2% |
| 2 | Primary Effusion Lymphoma | 45.2% |
| 3 | Burkitt Lymphoma | 35.3% |
| 4 | Plasmablastic lymphoma | 34.2% |
| 5 | Lymphoma, Follicular | 34.1% |
| 6 | T-Cell Lymphoma | 34.1% |
| 7 | Mantle cell lymphoma | 34.1% |
| 8 | Composite Lymphoma | 30.4% |
| 9 | Hodgkin Disease | 28.4% |
| 10 | Sezary Syndrome | 25.2% |
| 11 | Lymphoma, T-Cell, Cutaneous | 23.2% |
| 12 | Enteropathy-Associated T-Cell Lymphoma | 23.2% |
| 13 | Erythroplasia | 18.9% |
| 14 | Aberrant Crypt Foci | 18.9% |
| 15 | Mycosis Fungoides | 17.7% |
| 16 | Lymphomatoid Papulosis | 17.7% |
| 17 | Tumor Lysis Syndrome | 17.2% |
| 18 | Plasmacytoma | 16% |
| 19 | Leukoplakia | 15.9% |
| 20 | Barrett Esophagus | 15.7% |
| 21 | Actinic keratosis | 15.7% |
| 22 | Histiocytic Disorders, Malignant | 15.6% |
| 23 | Neoplasms, Neuroepithelial | 15.1% |
| 24 | Gliomatosis cerebri | 15.1% |
| 25 | Autoimmune Lymphoproliferative Syndrome | 15% |
| 26 | Lymphangioleiomyomatosis | 14.8% |
| 27 | Leukemia, Plasma Cell | 14.8% |
| 28 | Neuroectodermal Tumors | 14.8% |
| 29 | Primary amyloidosis | 14.8% |
| 30 | leukemia | 14.2% |
| 31 | Neoplasms, Germ Cell and Embryonal | 14.2% |
| 32 | Neoplasms, Glandular and Epithelial | 14.2% |
| 33 | Germ Cell Cancer | 14.2% |
| 34 | Lymphocele | 14.1% |
| 35 | Hamartoma | 13.9% |
| 36 | Neoplasms, Hormone-Dependent | 13.9% |
| 37 | Neoplasms, Multiple Primary | 13.9% |
| 38 | Paraneoplastic Syndromes | 13.9% |
| 39 | Neoplasms, Second Primary | 13.9% |
| 40 | Infectious Mononucleosis | 13.8% |
| 41 | Carcinoma 256, Walker | 13.8% |
| 42 | Meningioma | 13.2% |
| 43 | melanoma | 13.2% |
| 44 | Medulloblastoma | 13.1% |
| 45 | Melanoma, Experimental | 12.7% |
| 46 | Waldenstrom Macroglobulinemia | 12.6% |
| 47 | Multiple Myeloma | 12.6% |
| 48 | Lymphoma, Extranodal NK-T-Cell | 12.6% |
| 49 | Multiple Endocrine Neoplasia | 12.5% |
| 50 | Carcinosarcoma | 12.5% |
| 51 | Hemangiosarcoma | 12.5% |
| 52 | Leukemia, T-Cell | 12.5% |
| 53 | lymphangiosarcoma | 12.5% |
| 54 | Thymoma | 12.5% |
| 55 | Leukemia, B-Cell | 12.5% |
| 56 | Trophoblastic Neoplasms | 12.3% |
| 57 | Leukemia, Experimental | 12.3% |
| 58 | Carcinoma, Ehrlich Tumor | 12.1% |
| 59 | Dermoid Cyst | 12.1% |
| 60 | Carcinoma, Lewis Lung | 12.1% |
| 61 | Thymus Neoplasms | 11.7% |
| 62 | Cyst | 11.7% |
| 63 | Neoplastic Processes | 11.7% |
| 64 | Neoplastic Syndromes, Hereditary | 11.7% |
| 65 | Pregnancy Complications, Neoplastic | 11.7% |
| 66 | Neoplasms, Experimental | 11.6% |
| 67 | Adenoma, Acidophil | 11.3% |
| 68 | Ganglioneuroma | 11.3% |
| 69 | Glioma | 11.3% |
| 70 | Malignant Glioma | 11.3% |
| 71 | Heavy Chain Disease | 11.1% |
| 72 | Leukoplakia, Oral | 11.1% |
| 73 | Leukemia, Radiation-Induced | 10.8% |
| 74 | Splenic Neoplasms | 10.6% |
| 75 | Agammaglobulinemia | 10.5% |
| 76 | Carcinoid Tumor | 10.3% |
| 77 | Choriocarcinoma | 10.3% |
| 78 | Neurilemmoma | 10.3% |
| 79 | Hutchinson's Melanotic Freckle | 10.3% |
| 80 | Carcinoma, Lobular | 10.3% |
| 81 | Melanoma, Amelanotic | 10.3% |
| 82 | Sarcoma, Experimental | 10.3% |
| 83 | Sarcoidosis | 10.3% |
| 84 | Basal cell carcinoma | 10.3% |
| 85 | Carcinoma, Papillary | 10.3% |
| 86 | Squamous cell carcinoma | 10.3% |
| 87 | Chondrosarcoma | 10.3% |
| 88 | Craniopharyngioma | 10.3% |
| 89 | Cystadenoma | 10.3% |
| 90 | leiomyosarcoma | 10.3% |
| 91 | liposarcoma | 10.3% |
| 92 | Mesothelioma | 10.3% |
| 93 | synovial sarcoma | 10.3% |
| 94 | Neuroectodermal Tumor, Melanotic | 10.3% |
| 95 | Angiomyolipoma | 10.3% |
| 96 | Clear Cell Sarcoma of Soft Tissue | 10.3% |
| 97 | Alveolar Soft Part Sarcoma | 10.3% |
| 98 | Neuroendocrine Tumors | 10.3% |
| 99 | Sarcoma, Myeloid | 10.3% |
| 100 | Carcinoma, Basal Cell | 10.3% |
| 101 | Paraneoplastic Encephalomyelitis | 10% |
| 102 | Neoplasms, Radiation-Induced | 10% |
| 103 | Mammary Neoplasms, Experimental | 9.9% |
| 104 | Leukemia L1210 | 9.8% |
| 105 | Leukemia P388 | 9.8% |
| 106 | Acanthoma | 9.8% |
| 107 | Tuberous Sclerosis | 9.7% |
| 108 | Astrocytoma | 9.4% |
| 109 | Ependymoma | 9.4% |
| 110 | oligodendroglioma | 9.4% |
| 111 | Ganglioglioma | 9.4% |
| 112 | gliosarcoma | 9.4% |
| 113 | Anaplastic astrocytoma | 9.4% |
| 114 | Anaplastic Oligodendroglioma | 9.4% |
| 115 | Malignant histiocytosis | 9.4% |
| 116 | Histiocytic sarcoma | 9.4% |
| 117 | Hematologic Neoplasms | 9.4% |
| 118 | Retinoblastoma | 9.2% |
| 119 | Cystadenocarcinoma | 9.2% |
| 120 | Fibrosarcoma | 9.2% |
| 121 | Osteosarcoma | 9.2% |
| 122 | Mucoepidermoid Carcinoma | 9.2% |
| 123 | Malignant Carcinoid Syndrome | 8.9% |
| 124 | Adenoma | 8.8% |
| 125 | Ameloblastoma | 8.8% |
| 126 | Angiokeratoma | 8.8% |
| 127 | Carcinoma | 8.8% |
| 128 | Chordoma | 8.8% |
| 129 | Hemangioma | 8.8% |
| 130 | hemangiopericytoma | 8.8% |
| 131 | Lymphangioma | 8.8% |
| 132 | Mesenchymoma | 8.8% |
| 133 | Nevus | 8.8% |
| 134 | Teratoma | 8.8% |
| 135 | Hepatoblastoma | 8.8% |
| 136 | Mixed Tumor, Mullerian | 8.8% |
| 137 | Germinoma | 8.8% |
| 138 | Teratocarcinoma | 8.8% |
| 139 | Angiofibroma | 8.8% |
| 140 | Sarcoma | 8.8% |
| 141 | Epithelioma | 8.8% |
| 142 | Granuloma | 8.7% |
| 143 | Sarcoma 180 | 8.7% |
| 144 | Adenofibroma | 8.6% |
| 145 | Fibroadenoma | 8.6% |
| 146 | Malignant Fibrous Histiocytoma | 8.6% |
| 147 | Nephroblastoma | 8.6% |
| 148 | Multiple Endocrine Neoplasia Type 1 | 8.5% |
| 149 | Glioblastoma | 8.5% |
| 150 | Neuroblastoma | 8.5% |
| 151 | Glioblastoma Multiforme | 8.5% |
| 152 | Endometrial Stromal Sarcoma | 8.5% |
| 153 | Adenitis | 8.4% |
| 154 | Histiocytosis | 8.4% |
| 155 | Lymphadenitis | 8.4% |
| 156 | Lymphangitis | 8.4% |
| 157 | Lymphedema | 8.4% |
| 158 | Splenic Diseases | 8.4% |
| 159 | Thymus Hyperplasia | 8.4% |
| 160 | Pseudolymphoma | 8.4% |
| 161 | Lymphadenopathy | 8.4% |
| 162 | Basal Cell Nevus Syndrome | 8.3% |
| 163 | Paraproteinemias | 8.3% |
| 164 | Abdominal Neoplasms | 8.3% |
| 165 | Follicular cyst | 8.3% |
| 166 | Head and Neck Neoplasms | 8.3% |
| 167 | Mucocele | 8.3% |
| 168 | Pilonidal Cyst | 8.3% |
| 169 | Soft Tissue Neoplasms | 8.3% |
| 170 | Thoracic Neoplasms | 8.3% |
| 171 | Thyroglossal Cyst | 8.3% |
| 172 | Synovial Cyst | 8.3% |
| 173 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 8.3% |
| 174 | Leukemia, Large Granular Lymphocytic | 8.3% |
| 175 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 8.3% |
| 176 | Bowen's Disease | 8.1% |
| 177 | Paraganglioma | 8.1% |
| 178 | Rhabdomyosarcoma | 8.1% |
| 179 | Giant Cell Tumor of Bone | 8.1% |
| 180 | Ganglioneuroblastoma | 8% |
| 181 | Carcinoma, Pancreatic Ductal | 8% |
| 182 | Xeroderma Pigmentosum | 7.9% |
| 183 | Acoustic Neuroma | 7.9% |
| 184 | Neurofibrosarcoma | 7.7% |
| 185 | Dermatofibrosarcoma | 7.5% |
| 186 | Dermatofibrosarcoma Protuberans | 7.5% |
| 187 | Carcinoid Heart Disease | 7.3% |
| 188 | Hypergammaglobulinemia | 7.2% |
| 189 | Digestive System Neoplasms | 7.1% |
| 190 | Endocrine Gland Neoplasms | 7.1% |
| 191 | Eye Neoplasms | 7.1% |
| 192 | Nervous System Neoplasms | 7.1% |
| 193 | Transfusion Reaction | 7.1% |
| 194 | Hypotensive Transfusion Reaction | 7.1% |
| 195 | Lymphatic Abnormalities | 7.1% |
| 196 | Optic Nerve Glioma | 7.1% |
| 197 | Parathyroid Neoplasms | 7.1% |
| 198 | Peritoneal Neoplasms | 7.1% |
| 199 | Thyroid Neoplasm | 7.1% |
| 200 | Thyroid carcinoma | 7.1% |
| 201 | Vipoma | 7% |
| 202 | Bone neoplasms | 7% |
| 203 | Pancreatic Cyst | 7% |
| 204 | Skin Neoplasms | 7% |
| 205 | Pheochromocytoma | 7% |
| 206 | Alveolar rhabdomyosarcoma | 7% |
| 207 | Liver Neoplasms, Experimental | 7% |
| 208 | Breast Cyst | 6.9% |
| 209 | Mediastinal Cyst | 6.9% |
| 210 | Neoplasm Invasiveness | 6.9% |
| 211 | Neoplasm Metastasis | 6.9% |
| 212 | Neoplasm Recurrence, Local | 6.9% |
| 213 | Parovarian Cyst | 6.9% |
| 214 | Pericardial Cyst | 6.9% |
| 215 | Thymic Cyst | 6.9% |
| 216 | Carcinogenesis | 6.9% |
| 217 | Myxoid cyst | 6.9% |
| 218 | Metastasis | 6.9% |
| 219 | Monoclonal Gammopathy of Undetermined Significance | 6.5% |
| 220 | Hepatocellular Adenoma | 6.5% |
| 221 | Hydatidiform Mole | 6.5% |
| 222 | Pancreatic Neoplasm | 6.4% |
| 223 | Lymphangiectasis, Intestinal | 6.3% |
| 224 | Tracheal Neoplasms | 6.2% |
| 225 | Adenomatous Polyposis Coli | 6.2% |
| 226 | Adenocarcinoma | 6.2% |
| 227 | Carcinoma in Situ | 6.2% |
| 228 | Carcinoma, Transitional Cell | 6.2% |
| 229 | Phyllodes Tumor | 6.2% |
| 230 | Dysgerminoma | 6.2% |
| 231 | Hemangioendothelioma | 6.2% |
| 232 | Lipoma | 6.2% |
| 233 | Myoma | 6.2% |
| 234 | Myxoma | 6.2% |
| 235 | Neuroma | 6.2% |
| 236 | Papilloma | 6.2% |
| 237 | Pseudomyxoma Peritonei | 6.2% |
| 238 | Seminoma | 6.2% |
| 239 | Papillomatosis | 6.2% |
| 240 | Angiolipoma | 6.2% |
| 241 | Myelolipoma | 6.2% |
| 242 | Neoplasms, Bone Tissue | 6.2% |
| 243 | Neoplasms, Fibrous Tissue | 6.2% |
| 244 | Smooth Muscle Tumor | 6.2% |
| 245 | Adenomatosis, Pulmonary | 6.2% |
| 246 | Adenomatous Polyps | 6.2% |
| 247 | Carcinoma, Large Cell | 6.2% |
| 248 | Carcinoma, Small Cell | 6.2% |
| 249 | Desmoplastic Small Round Cell Tumor | 6.2% |
| 250 | Chondroma | 6.2% |
| 251 | Enchondroma | 6.2% |
| 252 | Mesoblastic Nephroma | 6.1% |
| 253 | Paraneoplastic Cerebellar Degeneration | 6.1% |
| 254 | Bone Marrow Neoplasms | 6.1% |
| 255 | Mucocutaneous Lymph Node Syndrome | 6% |
| 256 | insulinoma | 6% |
| 257 | Corpus Luteum Cyst | 5.9% |
| 258 | Ovarian Cysts | 5.9% |
| 259 | Leukemia, Myelomonocytic, Chronic | 5.8% |
| 260 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 5.8% |
| 261 | Precancerous Conditions | 5.8% |
| 262 | Prolactinoma | 5.8% |
| 263 | Growth Hormone-Secreting Pituitary Adenoma | 5.8% |
| 264 | Lambert-Eaton Myasthenic Syndrome | 5.7% |
| 265 | Gastrinoma | 5.6% |
| 266 | Glucagonoma | 5.6% |
| 267 | Autoimmune Diseases | 5.6% |
| 268 | Hypersensitivity | 5.6% |
| 269 | Immunologic Deficiency Syndromes | 5.6% |
| 270 | Immune reconstitution syndrome | 5.6% |
| 271 | Immune Reconstitution Inflammatory Syndrome | 5.6% |
| 272 | Retroperitoneal Neoplasms | 5.6% |
| 273 | Mastocytosis | 5.5% |
| 274 | Esophageal Neoplasms | 5.5% |
| 275 | Limbic Encephalitis | 5.4% |
| 276 | Thyroid Nodule | 5.3% |
| 277 | Leydig Cell Tumor | 5.2% |
| 278 | Choledochal Cyst | 5.2% |
| 279 | granulosa cell tumor | 5.2% |
| 280 | Carcinoma, Ovarian Epithelial | 5.2% |
| 281 | Peutz-Jeghers Syndrome | 5.1% |
| 282 | Hemangioma, Cavernous | 5% |
| 283 | Testicular Neoplasms | 5% |
| 284 | Adenoid Cystic Carcinoma | 4.9% |
| 285 | fibroma | 4.9% |
| 286 | Fibromatosis | 4.9% |
| 287 | Osteoblastoma | 4.9% |
| 288 | Osteoma | 4.9% |
| 289 | Rhabdomyoma | 4.9% |
| 290 | Chondromatosis | 4.9% |
| 291 | Adenocarcinoma, Clear Cell | 4.9% |
| 292 | Cholangiocarcinoma | 4.9% |
| 293 | Cervical Intraepithelial Neoplasia | 4.9% |
| 294 | Hemangioblastoma | 4.9% |
| 295 | Sarcoidosis, Pulmonary | 4.8% |
| 296 | Mastocytosis, Systemic | 4.7% |
| 297 | Mouth Neoplasms | 4.7% |
| 298 | Central Nervous System Neoplasms | 4.7% |
| 299 | Vascular Neoplasms | 4.7% |
| 300 | Adrenocortical carcinoma | 4.7% |
| 301 | Genital Neoplasms, Female | 4.6% |
| 302 | Pancreatic Pseudocyst | 4.6% |
| 303 | Lymphatic Metastasis | 4.6% |
| 304 | Neoplasms, Unknown Primary | 4.6% |
| 305 | Leukemic Infiltration | 4.6% |
| 306 | Breast Neoplasms, Male | 4.6% |
| 307 | Neoplasm Micrometastasis | 4.6% |
| 308 | Triple Negative Breast Neoplasms | 4.6% |
| 309 | Denys-Drash Syndrome | 4.6% |
| 310 | Opsoclonus-Myoclonus Syndrome | 4.5% |
| 311 | Sturge-Weber Syndrome | 4.5% |
| 312 | Gastrointestinal Stromal Tumors | 4.4% |
| 313 | Leukemia, Myeloid, Chronic-Phase | 4.4% |
| 314 | Myelitis, Transverse | 4.4% |
| 315 | Elephantiasis | 4.4% |
| 316 | Hypersplenism | 4.4% |
| 317 | Elephantiasis Nostras Verrucosa | 4.4% |
| 318 | neurofibroma | 4.4% |
| 319 | Nasopharyngeal carcinoma | 4.3% |
| 320 | Fibromatosis, Aggressive | 4.2% |
| 321 | Fibromatosis, Abdominal | 4.2% |
| 322 | Klatskin Tumor | 4.2% |
| 323 | Renal Cell Carcinoma | 4.2% |
| 324 | Papillary Renal Cell Carcinoma | 4.2% |
| 325 | Polycythemia Vera | 4.1% |
| 326 | Adrenal Gland Neoplasms | 4.1% |
| 327 | Gastrointestinal Neoplasms | 4.1% |
| 328 | Genital Neoplasms, Male | 4.1% |
| 329 | Liver neoplasms | 4.1% |
| 330 | Uveal Neoplasms | 4.1% |
| 331 | Mastocytoma | 4.1% |
| 332 | Urologic Neoplasms | 4% |
| 333 | Carcinoma, Endometrioid | 4% |
| 334 | Sebaceous Gland Neoplasms | 4% |
| 335 | Spinal Neoplasms | 4% |
| 336 | Nose Neoplasms | 4% |
| 337 | Polycystic Ovary Syndrome | 3.9% |
| 338 | Glomerulonephritis, Membranoproliferative | 3.9% |
| 339 | Palatal Neoplasms | 3.9% |
| 340 | Lymphoma | 3.8% |
| 341 | Cryoglobulinemia | 3.8% |
| 342 | Thrombocytopenic purpura | 3.8% |
| 343 | Splenic Infarction | 3.7% |
| 344 | Histiocytosis, Langerhans-Cell | 3.7% |
| 345 | Lymphomatoid Granulomatosis | 3.7% |
| 346 | Pituitary Adenoma | 3.6% |
| 347 | Pituitary Neoplasms | 3.6% |
| 348 | Autoimmune thrombocytopenia | 3.6% |
| 349 | Immune thrombocytopenic purpura | 3.6% |
| 350 | Meningeal Neoplasms | 3.5% |
| 351 | POEMS Syndrome | 3.3% |
| 352 | Splenic Rupture | 3.2% |
| 353 | Disseminated Intravascular Coagulation | 3.2% |
| 354 | Protein S Deficiency | 3.2% |
| 355 | ovarian neoplasm | 3.1% |
| 356 | Ear Neoplasms | 3.1% |
| 357 | Eyelid Neoplasms | 3.1% |
| 358 | Lung Neoplasms | 3.1% |
| 359 | Pleural Neoplasms | 3.1% |
| 360 | Transfusion-Related Acute Lung Injury | 3.1% |
| 361 | Dupuytren Contracture | 3.1% |
| 362 | Cell Transformation, Viral | 3% |
| 363 | Brain Neoplasms | 3% |
| 364 | Salivary Gland Neoplasms | 3% |
| 365 | Spinal Cord Neoplasms | 3% |
| 366 | Tongue Neoplasms | 3% |
| 367 | Lymphopenia | 3% |
| 368 | Urticaria Pigmentosa | 3% |
| 369 | Uterine Neoplasms | 3% |
| 370 | Vaginal Neoplasms | 3% |
| 371 | Vulvar Neoplasms | 3% |
| 372 | Uterine Cancer | 3% |
| 373 | Fallopian Tube Neoplasms | 3% |
| 374 | Meningeal Carcinomatosis | 3% |
| 375 | Anemia | 2.8% |
| 376 | Blood Coagulation Disorders | 2.8% |
| 377 | Blood Platelet Disorders | 2.8% |
| 378 | Bone Marrow Diseases | 2.8% |
| 379 | Hemorrhagic Disorders | 2.8% |
| 380 | Immune Complex Diseases | 2.8% |
| 381 | Leukocyte Disorders | 2.8% |
| 382 | Methemoglobinemia | 2.8% |
| 383 | Pancytopenia | 2.8% |
| 384 | Polycythemia | 2.8% |
| 385 | Sulfhemoglobinemia | 2.8% |
| 386 | Antiphospholipid Syndrome | 2.8% |
| 387 | Thrombophilia | 2.8% |
| 388 | Latex allergy | 2.8% |
| 389 | Erythrocytosis | 2.8% |
| 390 | Lymphoma, Non-Hodgkin | 2.8% |
| 391 | Pharyngeal Neoplasms | 2.7% |
| 392 | Central Nervous System Cysts | 2.7% |
| 393 | Bile Duct Neoplasms | 2.7% |
| 394 | gallbladder neoplasm | 2.7% |
| 395 | Intestinal Neoplasms | 2.7% |
| 396 | Penile Neoplasms | 2.7% |
| 397 | Prostatic Neoplasms | 2.7% |
| 398 | Stomach Neoplasms | 2.7% |
| 399 | Thrombocythemia, Essential | 2.6% |
| 400 | Bronchial Neoplasms | 2.6% |
| 401 | Multiple Pulmonary Nodules | 2.6% |
| 402 | Supratentorial Neoplasms | 2.5% |
| 403 | Zollinger-Ellison syndrome | 2.5% |
| 404 | Endometrial Neoplasms | 2.5% |
| 405 | Laryngeal neoplasm | 2.4% |
| 406 | Lymphohistiocytosis, Hemophagocytic | 2.4% |
| 407 | Schnitzler Syndrome | 2.4% |
| 408 | Erdheim-Chester Disease | 2.4% |
| 409 | Environmental Illness | 2.4% |
| 410 | Lupus Erythematosus, Systemic | 2.4% |
| 411 | Pregnancy Complications, Hematologic | 2.4% |
| 412 | Overlap syndrome | 2.4% |
| 413 | Thrombasthenia | 2.4% |
| 414 | Antithrombin III Deficiency | 2.4% |
| 415 | Protein C Deficiency | 2.4% |
| 416 | Bladder Neoplasm | 2.4% |
| 417 | Kidney Neoplasm | 2.4% |
| 418 | Ureteral Neoplasms | 2.4% |
| 419 | Urethral Neoplasms | 2.4% |
| 420 | Addison Disease | 2.3% |
| 421 | Pemphigus | 2.3% |
| 422 | Autoimmune thyroiditis | 2.3% |
| 423 | Primary Adrenal Insufficiency | 2.3% |
| 424 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.3% |
| 425 | Autoimmune hepatitis | 2.3% |
| 426 | Brain Stem Neoplasms | 2.3% |
| 427 | Hypopharyngeal Neoplasms | 2.2% |
| 428 | Pleural Effusion, Malignant | 2.2% |
| 429 | Hypopharyngeal Cancer | 2.2% |
| 430 | Parotid Neoplasms | 2.2% |
| 431 | Prostatic Neoplasms, Castration-Resistant | 2.2% |
| 432 | Nelson Syndrome | 2.2% |
| 433 | Choroid Plexus Papilloma | 2.2% |
| 434 | Hydrops Fetalis | 2.2% |
| 435 | Kernicterus | 2.2% |
| 436 | Wiskott-Aldrich Syndrome | 2.1% |
| 437 | Vitamin K Deficiency | 2.1% |
| 438 | Latent Autoimmune Diabetes in Adults | 2% |
| 439 | Tonsillar Neoplasms | 2% |
| 440 | Dermatitis Herpetiformis | 2% |
| 441 | Kounis Syndrome | 2% |
| 442 | Cerebellar Neoplasms | 2% |
| 443 | HIV Infections | 2% |
| 444 | Cecal Neoplasms | 2% |
| 445 | Duodenal Neoplasms | 2% |
| 446 | Afibrinogenemia | 1.9% |
| 447 | Factor VII Deficiency | 1.9% |
| 448 | Factor X Deficiency | 1.9% |
| 449 | Factor XII Deficiency | 1.9% |
| 450 | Hemophilia A | 1.9% |
| 451 | Activated Protein C Resistance | 1.9% |
| 452 | Factor II deficiency | 1.9% |
| 453 | Factor VIII Deficiency | 1.9% |
| 454 | Factor V deficiency | 1.9% |
| 455 | Factor XI Deficiency | 1.9% |
| 456 | Hypoprothrombinemias | 1.9% |
| 457 | Thrombocytosis | 1.9% |
| 458 | Job Syndrome | 1.9% |
| 459 | Eosinophilic Granuloma | 1.8% |
| 460 | Nasopharyngeal Neoplasms | 1.8% |
| 461 | Radicular Cyst | 1.8% |
| 462 | Appendiceal Neoplasms | 1.8% |
| 463 | Colonic Neoplasms | 1.8% |
| 464 | Rectal Neoplasms | 1.8% |
| 465 | Rheumatoid Arthritis | 1.8% |
| 466 | Juvenile arthritis | 1.8% |
| 467 | Colorectal Neoplasms | 1.8% |
| 468 | Graves Disease | 1.8% |
| 469 | Splenosis | 1.8% |
| 470 | Anti-Glomerular Basement Membrane Disease | 1.7% |
| 471 | Asthma, Aspirin-Induced | 1.6% |
| 472 | Paranasal Sinus Neoplasms | 1.6% |
| 473 | Chronic granulomatous disease | 1.6% |
| 474 | Anus Neoplasms | 1.5% |
| 475 | Sigmoid Neoplasms | 1.5% |
| 476 | anaphylaxis | 1.5% |
| 477 | Anemia, Hemolytic | 1.5% |
| 478 | Anemia, Macrocytic | 1.5% |
| 479 | Eosinophilia | 1.5% |
| 480 | Food Allergy | 1.5% |
| 481 | Hypoproteinemia | 1.5% |
| 482 | Leukopenia | 1.5% |
| 483 | Thrombocytopenia | 1.5% |
| 484 | Leukostasis | 1.5% |
| 485 | MYELODYSPLASTIC SYNDROME | 1.5% |
| 486 | Anaphylactic shock | 1.5% |
| 487 | Maxillary Sinus Neoplasms | 1.5% |
| 488 | Serum Sickness | 1.4% |
| 489 | Hemoglobinuria, Paroxysmal | 1.4% |
| 490 | Leukemoid Reaction | 1.4% |
| 491 | Ataxia Telangiectasia | 1.3% |
| 492 | Respiratory Hypersensitivity | 1.3% |
| 493 | Purpura, Thrombotic Thrombocytopenic | 1.3% |
| 494 | Anemia, Neonatal | 1.2% |
| 495 | Leukocytosis | 1.2% |
| 496 | Pelger-Huet Anomaly | 1.2% |
| 497 | Sick Building Syndrome | 1.2% |
| 498 | Pleocytosis | 1.2% |
| 499 | Multiple Chemical Sensitivity | 1.2% |
| 500 | Urticaria | 1.2% |
| 501 | Vasculitis, Leukocytoclastic, Cutaneous | 1.2% |
| 502 | Anemia, Sickle Cell | 1.2% |
| 503 | Thalassemia | 1.2% |
| 504 | HTLV-I Infections | 1.2% |
| 505 | Anemia, Diamond-Blackfan | 1.1% |
| 506 | Myasthenia Gravis | 1.1% |
| 507 | Uveomeningoencephalitic Syndrome | 1.1% |
| 508 | Drug Eruptions | 1.1% |
| 509 | Ecchymosis | 1.1% |
| 510 | Petechiae | 1.1% |
| 511 | Purpura | 1.1% |
| 512 | Granulomatosis with polyangiitis | 1% |
| 513 | Dermatitis, Allergic Contact | 1% |
| 514 | HIV Seropositivity | 1% |
| 515 | Stiff-Person Syndrome | 0.9% |
| 516 | Polyradiculoneuropathy | 0.9% |
| 517 | Polyradiculoneuritis | 0.9% |
| 518 | Acquired Immunodeficiency Syndrome | 0.9% |
| 519 | AIDS related complex | 0.9% |
| 520 | Felty Syndrome | 0.9% |
| 521 | Lupus Nephritis | 0.9% |
| 522 | Purpura, Hyperglobulinemic | 0.9% |
| 523 | Waterhouse-Friderichsen Syndrome | 0.9% |
| 524 | AIDS-Related Opportunistic Infections | 0.8% |
| 525 | Vasculitis, Central Nervous System | 0.8% |
| 526 | Dermatitis, Atopic | 0.8% |
| 527 | HIV Wasting Syndrome | 0.8% |
| 528 | Rheumatoid Vasculitis | 0.8% |
| 529 | Myasthenia Gravis, Autoimmune, Experimental | 0.8% |
| 530 | AIDS Dementia Complex | 0.8% |
| 531 | AIDS-Associated Nephropathy | 0.8% |
| 532 | Primary Myelofibrosis | 0.8% |
| 533 | Agranulocytosis | 0.8% |
| 534 | Anemia, Megaloblastic | 0.8% |
| 535 | Lymphocytosis | 0.8% |
| 536 | Myelofibrosis | 0.8% |
| 537 | Myeloid Metaplasia | 0.8% |
| 538 | Milk Allergy | 0.8% |
| 539 | Hypoalbuminemia | 0.8% |
| 540 | Wheat Hypersensitivity | 0.8% |
| 541 | Hypereosinophilic syndrome | 0.8% |
| 542 | bone marrow fibrosis | 0.8% |
| 543 | Thrombotic Microangiopathies | 0.8% |
| 544 | Hemolytic-Uremic Syndrome | 0.8% |
| 545 | Lupus Vasculitis, Central Nervous System | 0.8% |
| 546 | Sicca Syndrome | 0.7% |
| 547 | Sjogren's Syndrome | 0.7% |
| 548 | HIV-Associated Lipodystrophy Syndrome | 0.7% |
| 549 | Sickle Cell Trait | 0.7% |
| 550 | Fanconi Anemia | 0.6% |
| 551 | Eosinophilia-Myalgia Syndrome | 0.6% |
| 552 | Angioedema | 0.6% |
| 553 | Multiple Sclerosis | 0.6% |
| 554 | Shwartzman Phenomenon | 0.6% |
| 555 | Scurvy | 0.6% |
| 556 | Purpura Fulminans | 0.6% |
| 557 | Acute Generalized Exanthematous Pustulosis | 0.6% |
| 558 | Acute Chest Syndrome | 0.6% |
| 559 | Neuromyelitis Optica | 0.5% |
| 560 | Leukoencephalitis, Acute Hemorrhagic | 0.5% |
| 561 | Asthma | 0.5% |
| 562 | Niemann-Pick Disease, Type C | 0.5% |
| 563 | Encephalomyelitis, Acute Disseminated | 0.5% |
| 564 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.5% |
| 565 | Erythema Nodosum | 0.5% |
| 566 | Neuritis, Autoimmune, Experimental | 0.5% |
| 567 | Dermatitis, Photoallergic | 0.5% |
| 568 | Atypical Hemolytic Uremic Syndrome | 0.5% |
| 569 | Neutropenia | 0.5% |
| 570 | Aspergillosis, Allergic Bronchopulmonary | 0.5% |
| 571 | Guillain-Barre Syndrome | 0.5% |
| 572 | Pulmonary Eosinophilia | 0.4% |
| 573 | Eosinophilic Pneumonia | 0.4% |
| 574 | Toxic Epidermal Necrolysis | 0.4% |
| 575 | Stevens-Johnson Syndrome | 0.4% |
| 576 | Anemia, Pernicious | 0.4% |
| 577 | Pseudoxanthoma Elasticum | 0.4% |
| 578 | Giant Cell Arteritis | 0.4% |
| 579 | Temporal Arteritis | 0.4% |
| 580 | Asthma, Exercise-Induced | 0.3% |
| 581 | Status Asthmaticus | 0.3% |
| 582 | Multiple Sclerosis, Chronic Progressive | 0.3% |
| 583 | Multiple Sclerosis, Relapsing-Remitting | 0.3% |
| 584 | Febrile Neutropenia | 0.3% |
| 585 | Asthma, Occupational | 0.3% |
| 586 | Farmer's Lung | 0.3% |
| 587 | Angioedemas, Hereditary | 0.3% |
| 588 | Hay fever | 0.3% |
| 589 | Rhinitis, Allergic, Perennial | 0.3% |
| 590 | Hereditary Angioedema Type III | 0.2% |
| 591 | Hereditary Angioedema Types I and II | 0.2% |
| 592 | Miller Fisher Syndrome | 0.2% |